X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
abridged index medicus (2) 2
antineoplastic agents, hormonal - therapeutic use (2) 2
aromatase inhibitors - therapeutic use (2) 2
bone density conservation agents - therapeutic use (2) 2
breast cancer (2) 2
breast neoplasms - drug therapy (2) 2
chemotherapy (2) 2
colorectal cancer (2) 2
diphosphonates - therapeutic use (2) 2
disease-free survival (2) 2
drug therapy, combination (2) 2
female (2) 2
goserelin - therapeutic use (2) 2
humans (2) 2
imidazoles - therapeutic use (2) 2
index medicus (2) 2
medicine, general & internal (2) 2
nitriles - therapeutic use (2) 2
premenopause (2) 2
tamoxifen - therapeutic use (2) 2
triazoles - therapeutic use (2) 2
womens health (2) 2
acids (1) 1
adult (1) 1
antineoplastic agents, hormonal - adverse effects (1) 1
aromatase inhibitors - adverse effects (1) 1
austrian breast (1) 1
bisphosphonate-associated osteonecrosis (1) 1
bone density conservation agents - adverse effects (1) 1
bone loss (1) 1
breast neoplasms - surgery (1) 1
cancer therapies (1) 1
care and treatment (1) 1
chemotherapy, adjuvant (1) 1
clinical trials (1) 1
confidence intervals (1) 1
cytotoxicity (1) 1
data interpretation, statistical (1) 1
delta-t-cells (1) 1
diphosphonates - adverse effects (1) 1
endocrine therapy (1) 1
estrogen antagonists - adverse effects (1) 1
estrogen antagonists - therapeutic use (1) 1
follow-up studies (1) 1
function tests (1) 1
health aspects (1) 1
hospitals (1) 1
imidazoles - adverse effects (1) 1
menopause (1) 1
middle aged (1) 1
multiple-myeloma (1) 1
nitriles - adverse effects (1) 1
ovarian ablation (1) 1
postmenopausal women (1) 1
radiation therapy (1) 1
receiving adjuvant letrozole (1) 1
receptors, estrogen - analysis (1) 1
solid tumors (1) 1
tamoxifen (1) 1
tamoxifen - adverse effects (1) 1
triazoles - adverse effects (1) 1
usage (1) 1
vitamin d (1) 1
zoledronic acid (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 02/2009, Volume 360, Issue 7, pp. 679 - 691
This large trial tested the effect of adding zoledronic acid to adjuvant endocrine treatment (goserelin plus tamoxifen or anastrozole) in premenopausal women... 
RECEIVING ADJUVANT LETROZOLE | MULTIPLE-MYELOMA | OVARIAN ABLATION | BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS | MEDICINE, GENERAL & INTERNAL | BONE LOSS | SOLID TUMORS | TAMOXIFEN | DELTA-T-CELLS | POSTMENOPAUSAL WOMEN | AUSTRIAN BREAST | Breast Neoplasms - surgery | Triazoles - adverse effects | Follow-Up Studies | Humans | Middle Aged | Receptors, Estrogen - analysis | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Adult | Female | Chemotherapy, Adjuvant | Imidazoles - therapeutic use | Drug Therapy, Combination | Goserelin - therapeutic use | Aromatase Inhibitors - therapeutic use | Diphosphonates - adverse effects | Triazoles - therapeutic use | Bone Density Conservation Agents - adverse effects | Premenopause | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Breast Neoplasms - drug therapy | Disease-Free Survival | Estrogen Antagonists - therapeutic use | Tamoxifen - therapeutic use | Estrogen Antagonists - adverse effects | Tamoxifen - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Zoledronic acid | Care and treatment | Usage | Breast cancer | Health aspects | Function tests (Medicine) | Chemotherapy | Acids | Womens health | Menopause | Colorectal cancer | Cytotoxicity | Radiation therapy | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.